Prescription Hair Loss & Hair Removal Drugs Market - Forecast(2024 - 2030)

The Prescription Hair Loss & Hair Removal Drugs Market size is estimated to reach $44.1 billion by 2027, growing at a CAGR of 6.9% during the forecast period 2022-2027. Dermatologists prescribe spironolactone to treat hair loss. Prescription pills for hair loss may include finasteride. The best medicine for hair regrowth in North America could possibly be Rogaine to treat male pattern baldness. The most popular hair fall control tablet names consist of Minoxidil and Finasteride. The rising count of organizations spreading consciousness for hair redevelopment is set to drive the Prescription Hair Loss & Hair Removal Drugs Market. The increasing count of millennials enduring hair loss and requiring prescription pills for hair loss is set to propel the growth of the Prescription Hair Loss & Hair Removal Drugs Industry during the forecast period 2022-2027.

Prescription Hair Loss & Hair Removal Drugs Market Report Coverage

The “Prescription Hair Loss & Hair Removal Drugs Market Report - Forecast (2022-2027)” by IndustryARC, covers an in-depth analysis of the following segments in the Prescription Hair Loss & Hair Removal Drugs Market.

by Drug Type: Hair Loss Medications (Finasteride and Corticosteroids), Oral Contraceptive Pills or Birth Control Pills and Hair Removal Medications (Vaniqa, Spironolactone, Flutamide, Finasteride, Ketoconazole and Fluridil).
by Gender: Male and Female.
by Geography: North America (the US, Canada and Mexico), Europe (Germany, France, the UK, Italy, Spain, Russia and the Rest of Europe), Asia-Pacific (China, Japan, South Korea, India, Australia & New Zealand and the Rest of Asia-Pacific), South America (Brazil, Argentina, Chile, Colombia and the Rest of South America) and the Rest Of The World (the Middle East and Africa).

Key Takeaways

• Geographically, North America (Prescription Hair Loss & Hair Removal Drugs Market share) accounted for the highest revenue share in 2021 and it is poised to dominate the market over the period 2022-2027 dueg to the enormous count of women enduring appreciable hair loss, with Rogaine possibly being the best medicine for hair regrowth in North America.
• The growth of the Prescription Hair Loss & Hair Removal Drugs Market is being driven by the increasing predominance of hair loss. However, side-effects of hair loss medicines for men are some of the major factors hampering the growth of the Prescription Hair Loss & Hair Removal Drugs Market.
• Prescription Hair Loss & Hair Removal Drugs Market Detailed Analysis on the Strengths, Weaknesses and Opportunities of the prominent players operating in the market would be provided in the Prescription Hair Loss & Hair Removal Drugs Market report. 

Prescription Hair Loss & Hair Removal Drugs Market Segment Analysis - by Drug Type

The Prescription Hair Loss & Hair Removal Drugs Market based on drug type can be further segmented into Hair Loss Medications, Oral Contraceptive Pills or Birth Control Pills and Hair Removal Medications. The Hair Loss Medications Segment held the largest Prescription Hair Loss & Hair Removal Drugs Market share in 2021. This growth is driven by the increasing predominance of hair loss. The extensive application of Rogaine, the best medicine for hair regrowth in North America is further propelling the growth of the Hair Loss Medications segment. Furthermore, the Hair Removal Medications segment is estimated to grow with the fastest CAGR of 7.1% during the forecast period 2022-2027 due to the rising application of hair removal pills, medicines and creams with dermatologists providing hair removal treatments including laser hair removal and prescription cream.

Prescription Hair Loss & Hair Removal Drugs Market Segment Analysis - by Gender

The Prescription Hair Loss & Hair Removal Drugs Market based on gender can be further segmented into Male and Female. The Males Segment held the largest Prescription Hair Loss & Hair Removal Drugs Market share in 2021. This growth is driven by the increasing predominance of hair loss in men. As per statistics, men are much more inclined to endure hair loss than women. As per the American Hair Loss Association, by the age of thirty-five, nearly two-thirds of men would have lost slight hair. The greater testosterone level in men is further propelling the growth of this segment. Furthermore, the Males segment is estimated to grow with the fastest CAGR of 7.3% during the forecast period 2022-2027, owing to the rising pervasiveness of pattern baldness in men resulting in greater hair loss.

Prescription Hair Loss & Hair Removal Drugs Market Segment Analysis - by Geography

The Prescription Hair Loss & Hair Removal Drugs Market based on geography can be further segmented into North America, Europe, Asia-Pacific, South America and the Rest of the World. North American (Prescription Hair L& Hair Removal Drugs Market) dominated the Prescription Hair Loss & Hair Removal Drugs Market with a share of 32% of the overall market in 2021. The growth of this region is driven by the increasing trend of smoking among females in the North American region. The surging novel hair loss products are further propelling the growth of the Prescription Hair Loss and Hair Removal Market in the North American region.

Furthermore, the Asia-Pacific region is estimated to be the region with the fastest CAGR over the forecast period 2022-2027. This growth is fueled by the factors like proliferating inclination toward western culture in the Asia-Pacific region. The existence of China is further fueling the progress of the Prescription Hair Loss & Hair Removal Drugs Market in the Asia-Pacific region.

Prescription Hair Loss & Hair Removal Drugs Market Drivers

Increasing Female Pattern Hair Loss:

Female pattern hair loss influences nearly 40% of women aged 50. As per a physician, the root cause of hair loss determines its treatment. For inflammation, topical or injectable cortisone can assist. If associated with aging, topical medications like minoxidil and oral medications can be utilized. Spironolactone, finasteride, dutasteride and oral minoxidil are prescription pills for hair loss that are androgenic. All these factors fuel the growth of the Prescription Hair Loss & Hair Removal Drugs Market during the forecast period 2022-2027.

Soaring Applications of Hair Growth Products:

The most popular hair fall control tablet names may involve Minoxidil (Rogaine) and Finasteride (Propecia). As per Healthline, Women’s Rogaine 5% Minoxidil Foam has been ranked best for women including 5% minoxidil as an essential constituent. As per a 2019 investigation, Rogaine performs by boosting hair growth and decreasing hair loss, making it great for female and male pattern baldness. It can also be utilized for alopecia and eyebrow density. The soaring applications of hair growth products and the most popular hair fall control tablet names are therefore driving the growth of the Prescription Hair Loss & Hair Removal Drugs Market during the forecast period 2022-2027.

Prescription Hair Loss & Hair Removal Drugs Market Challenge

High Cost of Prescription Pills for Hair Loss:

By age 40, 40% of women would deal with hair loss to a certain degree. Treatment with prescription pills for hair loss may delay hair loss and assist in regrowing hair. However, one may not acquire as much growth as anticipated. One needs to keep partaking in the medication. Else, any regrown hair would fall. The provincial health plan or private health insurance possibly would not cover the medication and the medications can be expensive. These issues are thus hampering the growth of the Prescription Hair Loss & Hair Removal Drugs Market.

Prescription Hair Loss & Hair Removal Drugs Industry Outlook

Increasing clinical investigations, novel product launches, mergers and acquisitions and R&D activities are key strategies adopted by players in the Prescription Hair Loss & Hair Removal Drugs Market. The top 10 companies in the Prescription Hair Loss & Hair Removal Drugs Market are:

1. Merck & Co., Inc.
2. F. Hoffmann-La Roche Ag
3. Sandoz
4. Teva Pharmaceuticals
5. Advacare Pharma
6. Accord Healthcare
7. Alkem Labs Ltd
8. Aurobindo Pharma Ltd
9. Cipla Limited
10. Dr. Reddy's Labs Inc.

Recent Developments

• In August 2022, Accord Healthcare introduced generic medication. These medications are directed at treating brain tumors and blood cancers. Carmustine has been included in the line of chemotherapy medications.
• In September 2021, Dr. Reddy’s introduced medication for female pattern loss. The prescription medication Minoxidil topical solution 2 percent and 5 percent were introduced. This was performed for the treatment of female pattern hair loss (FPHL).
• In March 2021, Alkem Laboratories, in collaboration with ABCD Technologies, announced to invest in healthcare services. The goal is to digitize healthcare infrastructure in India.

Relevant Reports:

Hair Removal Devices Market - Industry Analysis, Market Size, Share, Trends, Application Analysis, Growth and Forecast Analysis
Report Code: HCR 25907

Hair Care Ingredients Market - Industry Analysis, Market Size, Share, Trends, Application Analysis, Growth and Forecast Analysis
Report Code: CPR 0115

Professional Hair Care Market - Industry Analysis, Market Size, Share, Trends, Application Analysis, Growth and Forecast Analysis
Report Code: CPR 0002